Contact Supplier

Contact Supplier

To get in touch with HAPILA GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    Showing advanced API and synthesis capabilities at ChemSpec Europe 2025 in Cologne

    news-releasesHAPILA GmbH
    May 28th 2025

    Gera, Germany: – For the eighth year in a row, High-potency active ingredient specialist CDMO HAPILA GmbH be a high-profile presence at the influential ChemSpec Europe trade show, this time in Köln (Cologne).

    HAPILA has a distinctive identity at the event as a contract developer and manufacturer that also markets its own developed active pharma ingredients.

    Broad range offers

    Accordingly, HAPILA’s stand at Booth 4C40 at the KölnMesse exhibition center will showcase its services in synthesis development, scale up of existing synthesis, particle design and the development of difficult purification of small molecules, as well as invite partners for its own APIs and those under development, such as its innovative anti-TB agent BTZ-043.

    The stand will also feature the work of HAPILA’s trusted marketing and sales partner, Transo-Pharm Handels GmbH.

    Deepening relationships

    HAPILA CEO Dr. Uwe Müller will head the event team that also includes Development Project Manager Development Dr. Thomas Rosin and Head of Quality Control Kristin Kirmße, both of whom joined Dr. Müller on stand at last year’s ChemSpec in Düsseldorf. Once again, the HAILA stand will serve hot and cold drinks.

    Dr. Müller commented: “We have been exhibiting at this fair every year since 2016, as a great platform to meet business partners and suppliers and get to know new customers. We use ChemSpec to meet our long-standing business partners in person, to discuss our future strategy or simply to refresh personal contacts.”

    “For 2025, we already have several meetings booked with potential partners regarding our wide expertise at the API field as well with our technological know-how to look for interested enterprises. We invite everyone involved in advanced pharmaceutical processes, whether start-ups or established companies, to come to our booth, enjoy some refreshment, and talk about their needs in synthesis and development of active ingredients.”

    About HAPILA GmbH

    HAPILA GmbH is a contract developing and manufacturing organization (CDMO) that provides high-value services to pharma, biotech and fine chemicals client companies in the development and cGMP manufacture of active pharmaceutical ingredients (APIs).

    HAPILA is an independent company with particular experience in GMP-related development and GMP manufacturing, offering a fully regulated service for API (IMPD, ASMF) to very high scientific and quality assurance (QA) levels.

    It supports the development and manufacture of drug products with patented processes and in-depth experience in the API value-creation chain from synthesis through purification to particle design.

    The company’s mission is to supply exclusive products of the highest quality, potency and safety in compliance with GMP and environmental protection guidelines. All HAPILA teamwork is focused on product quality and customer satisfaction.

    All HAPILA chemical synthesis is carried out in-house at its GMP certified laboratories at Gera, Thuringia, in east-central Germany.

    When combined with purification and particle design, HAPILA’s chemical synthesis services cover the complete API value-creation chain, enabling it to be a highly efficient bridge-builder between API production and pharmaceutical end-use.

    For more information, visit: www.hapila.de/ecom

    About ChemSpec Europe 2025

    The International Exhibition for Fine and Specialty Chemicals, ChemSpec Europe, is the continent’s premier sourcing and networking event for manufacturers, suppliers and distributors of fine and specialty chemicals. ChemSpec Europe is renowned for its specialized profile, presenting visitors and exhibitors with a platform to share knowledge about products and solutions.

    The 38th ChemSpec Europe expo (ChemSpec 2025) will again be a two-day event opening June 4 at the Messe Exhibition Center in Köln, Germany. The show is projected to surpass the 2024 show in Düsseldorf by attracting almost 5,000 visitors and featuring more than 400 exhibitors from 72 countries worldwide.

    The event is organized by Mack-Brooks Exhibitions with further information at https://www.chemspeceurope.com/en-gb/about.html

    Resources

    Click on HAPILA at ChemSpec 2025 to see exhibitor profile.
    Follow Hapila on LinkedIn.
    Follow Transo-Pharm Germany on LinkedIn.

    Showing advanced API and synthesis capabilities at ChemSpec Europe 2025 in Cologne
    Showing advanced API and synthesis capabilities at ChemSpec Europe 2025 in Cologne

    HAPILA CEO Dr. Uwe Müller (left) with Head of Quality Control Kristin Kirmße and Project Manager Development Dr. Thomas Rosin at ChemSpec 2024, Düsseldorf. All three will represent HAPILA at this year’s show.

    Showing advanced API and synthesis capabilities at ChemSpec Europe 2025 in Cologne

    HAPILA CEO Dr. Uwe Müller (left) with Project Manager Development Dr. Thomas Rosin on stand at ChemSpec 2024 in Düsseldorf, with refreshment area seen in background.

    HAPILA GmbH

    Contact Information
    Address: Otto-Schott-Str. 9, 07552 Gera, Germany
    Telephone No: +49 365 2058 6910
    Email Address: [email protected]

    Contact HAPILA GmbH

    Simply fill out the form below to contact HAPILA GmbH now.

    Send HAPILA GmbH a Message